Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation

Citation
Gi. Kemming et al., Inhaled nitric oxide (NO) for the treatment of early allograft failure after lung transplantation, INTEN CAR M, 24(11), 1998, pp. 1173-1180
Citations number
38
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
INTENSIVE CARE MEDICINE
ISSN journal
03424642 → ACNP
Volume
24
Issue
11
Year of publication
1998
Pages
1173 - 1180
Database
ISI
SICI code
0342-4642(199811)24:11<1173:INO(FT>2.0.ZU;2-S
Abstract
Objective: Inhalation of high concentrations of nitric oxide (NO) has been shown to improve gas exchange and to reduce pulmonary vascular resistance i n individuals with ischemia-reperfusion injury following orthotopic lung tr ansplantation. We assessed the cardiopulmonary effects of low doses of NO i n early allograft dysfunction following lung transplantion. Design: Prospective clinical dose-response study. Setting: Anesthesiological intensive care unit of a university hospital. Patients and participants: 8 patients following a single or double lung tra nsplantation who had a mean pulmonary arterial pressure (PAP) in excess of 4.7 kPa (35 mmHg) or an arterial oxygen tension/fractional inspired oxygen ratio (PaO2/FIO2) of less than 13.3 kPa (100 mmHg). Interventions: Gaseous NO was inhaled in increasing concentrations (1, 4 an d 8 parts per million, each for 15 min) via a Siemens Servo 300 ventilator. Measurements and results: Cardiorespiratory parameters were assessed at bas eline, after each concentration of NO, and 15 min after withdrawal of the a gent [statistics: median (25th/75th percentiles Q1/ 03), I:ANOVA, Dunnett's test, p < 0.05]. Inhaled NO resulted in a significant, reversible, dose-de pendent, selective reduction in PAP from 5.5(5.2/6.0) kPa at control to 5.1 (4.7/5.6) kPa at 1 ppm, 4.9(4.3/ 5.3) kPa at 4 ppm, and to 4.7(4.1/ 5.1) kP a at 8 ppm. PaO2 increased from 12.7(10.4/17.1) to 19.2(12.4/ 26.0) kPa at 1 ppm NO, to 23.9(4.67/ 26.7) kPa at 4 ppm NO and to 24.5(11.9/28.7) kPa at 8 ppm NO. All patients responded to NO inhalation (either with PAP or PaO2 ), all were subject to long-term inhalation (1-19 days). All were successfu lly weaned from NO and were discharged from the intensive care unit. Conclusion: The present study demonstrates that low-dose inhaled NO may be an effective drug for symptomatic treatment of hypoxemia and/or pulmonary h ypertension due to allograft dysfunction subsequent to lung transplantation .